Ludwig Burger, Pushkala Aripaka
(Adds comments from news conference, reaction)
Jan 29 (Reuters) - Europe’s medicines regulator on Friday approved AstraZeneca and Oxford University’s COVID-19 vaccine for people over the age of 18, the third vaccine to be cleared for use in the European Union.
The AstraZeneca vaccine demonstrated an efficacy of around 60% in the trials on which the decision was based, the European Medicines Agency (EMA) said in a statement bit.ly/3pwGYlx.
That is well below the level of protection shown by authorised vaccines from Pfizer and its German partner BioNTech and rival Moderna, which were around 95% effective in preventing symptomatic illness in pivotal trials.
Freigabe für dritten Impfstoff in der EU: Ein Vakzin mit Diskussionsbedarf | Tiroler Tageszeitung Online
tt.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tt.com Daily Mail and Mail on Sunday newspapers.
Astra-Zeneca-Impfstoff: Auch die über 65-Jährigen impfen?
kurier.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kurier.at Daily Mail and Mail on Sunday newspapers.